Novartis AG Common Stock (NVS)

Biotech stocks operate under a core ethos. While there’s been much talk about financially viable sectors – from tech to cryptocurrencies to even precious metals…

The 3 Most Undervalued Healthcare Stocks to Buy in June 2024

By Josh Enomoto, InvestorPlace Contributor Jun 4, 2024

When it comes to seeking discounts, investors may do well with undervalued healthcare stocks. Primarily, that’s because with this sector, you’re dealing with a permanently…

7 Pharma Stocks Harnessing AI Brainpower for Big Breakthroughs

By Alex Sirois, InvestorPlace Contributor May 16, 2024

AI continues to impact pharma stocks to buy in a major way, with these shares particularly well positioned as things heat up.

NVS Stock Earnings: Novartis Beats EPS, Beats Revenue for Q1 2024

By InvestorPlace Earnings Apr 23, 2024

NVS stock results show that Novartis beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Novartis Layoffs 2024: What to Know About the Latest NVS Job Cuts

By William White, InvestorPlace Writer Apr 10, 2024

Novartis layoffs will see the healthcare company cut 680 jobs in the U.S. and Switzerland over the next two to three years.

Harnessing AI for Drug Discovery: Top 3 Stocks to Watch

By Joey Frenette, InvestorPlace Contributor Mar 26, 2024

As biotech innovators look to AI to smoothen out the drug discovery process, the leaders in the scene could stand to benefit greatly.

3 Stocks Primed for Exponential Returns by 2034

By Chandler Capital, InvestorPlace Contributor Mar 1, 2024

As investors, It's always good to look at things long-term. Here are three stocks that are primed for exponential returns in ten years.

7 Contrarian Biotech Stocks to Consider Amid Sector Weakness

By Josh Enomoto, InvestorPlace Contributor Feb 15, 2024

Last October, life sciences giant Thermo Fisher Scientific (NYSE:TMO) inadvertently laid out the case for contrarian biotech stocks. According to Reuters, the company revealed that…

VYGR Stock Alert: The $1.2 Billion Reason Voyager Therapeutics Is Up Today

By Dana Blankenhorn, InvestorPlace Contributor Jan 2, 2024

VYGR stock is in focus as analysts expect more pharma deals in 2024, although some think these deals will be sunk by the Biden administration.

3 Healthcare Stocks to Pick Up Before the Year-End Rally

By Muslim Farooque, InvestorPlace Contributor Nov 28, 2023

Explore the potential of healthcare stocks as the U.S. charges ahead with $4.3 trillion in healthcare spending

7 Undervalued Stocks to Buy Before Everyone Else

By Chandler Capital, InvestorPlace Contributor Oct 26, 2023

Buy these undervalued stocks while they trade at a significant discount compared to their intrinsic valuations.

7 Healthcare Stocks to invest in for a Healthy Future

By Gabriel Osorio-Mazzilli, InvestorPlace Contributor Oct 20, 2023

Healthcare stocks may be one of the few winning sectors considering today's economic uncertainty and market turns. Here are the winners.

SDZNY Stock: 7 Things to Know as Novartis Spinoff Sandoz Starts Trading Today

By William White, InvestorPlace Writer Oct 4, 2023

Sandoz (SDZNY) stock is a hot topic among traders on Wednesday as the company starts trading after a spinoff from Novartis.

NVS Stock Alert: Novartis Shareholders Approve Sandoz Spinoff

By William White, InvestorPlace Writer Sep 15, 2023

Novartis (NVS) stock is rising higher on Friday after the company announced approval for the spinoff of its generic drugs business Sandoz.

The 7 Best Dividend Stocks to Protect Your Portfolio From Global Chaos

By Josh Enomoto, InvestorPlace Contributor Jul 24, 2023

With global events only rising in entropy, investors ought to consider these best dividend stocks for portfolio protection.

7 Top Growth Stocks to Watch for H2 2023

By Louis Navellier and the InvestorPlace Research Staff Jun 29, 2023

Many growth stocks still haven't completely recovered from their 2022 losses, so they have plenty of opportunities to do so in H2 2023.

Why Is AVROBIO (AVRO) Stock Up 83% Today?

By William White, InvestorPlace Writer May 22, 2023

AVROBIO (AVRO) stock is seeing massive gains on Monday as the company sells one of its gene therapies to Novartis (NVS).

3 Drug Stocks With Promising Pipelines for 2023

By Alex Sirois, InvestorPlace Contributor Jan 23, 2023

These 3 drug stocks with promising pipelines are in position to reward investors in 2023 due to multiple factors.

3 Biotech Stocks Smart Investors Should Be Buying Up Now

By Chris MacDonald, InvestorPlace Contributor Nov 24, 2022

These three biotech stocks could be among the best ways to play this uncertain market for those looking for long-term growth.

7 Safe Havens All Investors Should Have Exposure to in 2022

By Chris Lau, InvestorPlace Contributor Sep 22, 2022

Few stocks with deep value and growth prospects offer upside and safe havens for investors, with those picks the exception.

Novartis AG Common Stock (NVS)

NVS Stock Earnings: Novartis Beats EPS, Beats Revenue for Q2 2024

The 7 Most Undervalued Healthcare Stocks to Buy in July 2024

3 Healthcare Stocks Injecting AI for Big Gains

The 3 Most Undervalued Pharma Stocks to Buy in July 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Novartis AG Common Stock (NVS)

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

NVS Stock Predictions, Articles, and Novartis AG Common Stock News

Subscriber Sign in